WASHINGTON, D.C. August 25, 2014 Following is a statement from the American Cancer Society Cancer Action Network (ACS CAN) on the Drug Enforcement Administration 's (DEA) move to restrict access to hydrocodone combination products.
WASHINGTON, D.C. August 21, 2014 A majority of states are not measuring up on legislative solutions that prevent and fight cancer, according to a new report released today by the American Cancer Society Cancer Action Network (ACS CAN).
The report, Achieving Balance in State Pain Policy: A Progress Report Card (CY 2013)æshows the extent that state policies can support pain management and patient care.
WASHINGTON, D.C. April 28, 2014 The American Cancer Society Cancer Action Network (ACS CAN) submitted comments to the Drug Enforcement Administration (DEA) today in opposition to the agency 's proposal to restrict access to hydrocodone combination products (HCPs).
WASHINGTON, D.C. August 15, 2013 A majority of states are not measuring up on legislative solutions that prevent and fight cancer, according to a new report released today by the American Cancer Society Cancer Action Network (ACS CAN).
WASHINGTON, DC A growing number of states are enacting policy measures that promote the delivery of effective pain management, according to a report released today.
WASHINGTON, D.C. April 23, 2013 Rep. Emanuel Cleaver (D-Mo.) and Rep.
WASHINGTON, D.C. March 22, 2013 Sen. Ron Wyden (D-Ore.) and Rep. Eliot Engel (D-N.Y.) introduced legislation yesterday that aims to reduce suffering and improve the quality of life of patients undergoing care for serious illnesses such as cancer.
WASHINGTON, D.C. January 25, 2013 An American Cancer Society expert testified today at a meeting of the Food and Drug Administration (FDA) Drug Safety and Risk Management Advisory Committee on the potential danger to cancer patients of rescheduling certain pain medications.